Dissolvable Psilocybin Strips Might Be the Future of Psychedelic Drug Treatments
In 2019, the United States FDA identified psilocybin, which is a psychoactive element in psychedelic mushrooms, as a breakthrough therapy. This means that enough evidence has been provided that indicates that a new treatment may be far more effective than the current treatments available. It also means that clinical trials can now be advanced into the drug testing phase. Companies who have been researching psilocybin would do well to grab this opportunity. In this case, psilocybin-assisted therapy has been used as therapy for MDD, short for Major Depressive Disorder and shows promise, in comparison to results using antidepressants. While many…